Early detection of prostate cancer currently relies on screening with the PSA test, which does not clearly distinguish between prostate cancer and less serious conditions, and as a result many men are subjected to unnecessary prostate biopsies. There are over 1 million prostate biopsies performed in the US each year. Only 20% detect aggressive prostate cancer while 80% of prostate biopsies are either negative or detect a low-grade, non-life threatening form of prostate cancer.
The 4Kscore Test can help reduce the number of unnecessary biopsies, by measuring a man’s risk of having aggressive prostate cancer. If that risk is low a patient, in consultation with his Urologist, may decide not to have a prostate biopsy and avoid the associated pain and complications such as bleeding and infection that can result from the biopsy procedure.
How do I know whether I have aggressive prostate cancer?